Kyntra Bio (KYNB) Gross Margin (2018 - 2026)
Kyntra Bio (KYNB) reported Gross Margin of 99.86% for Q2 2026, up 6.17 percentage points from 93.69% a year earlier and up 109.71 percentage points from the prior quarter.
Powered by 
Analysis
Kyntra Bio (KYNB) Gross Margin (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kyntra Bio's Gross Margin came in at 41.26%, down 132.73 percentage points year-over-year; for FY2025, it came in at 91.37%, up 43.90 percentage points from FY2024.
- Gross Margin has a five-year change of -3.60 percentage points (FY2020 to FY2025).
- By year, Gross Margin came in at 47.47% in FY2024 (-44.07 pp), 91.53% in FY2023 (+5.94 pp), 85.59% in FY2022 (-8.94 pp) and 94.53% in FY2021 (-0.44 pp).
- The Q2 2026 figure ranks as the highest quarterly Gross Margin since Q4 2024.
- Year over year, Gross Margin gained in four of the last seven quarters, with an average year-over-year change of -30.70 percentage points.
- The high point for year-over-year Gross Margin in five years was Q1 2025 (a gain of 74.95 percentage points); the low point was Q4 2025 (a drop of 208.25 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -9.84% (Q1 2026), 78.23% (Q4 2025) and 94.61% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.02 Bn | 1,101.60 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 366.78 Bn | 321.16 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 297.96 Bn | 261.95 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 235.44 Bn | 190.84 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 190.69 Bn | 164.89 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 169.52 Bn | 116.16 Bn | 10.94 Bn | 72.78% |
| 10 | Kyntra Bio | 21.21 Mn | -386.73 Mn | 1.47 Mn | 99.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.86% |
| Mar 31, 2026 | -9.84% |
| Dec 31, 2025 | 78.23% |
| Sep 30, 2025 | 94.61% |
| Jun 30, 2025 | 93.69% |
| Mar 31, 2025 | 90.80% |
| Dec 31, 2024 | 286.48% |
| Sep 30, 2024 | 39.02% |
| Jun 30, 2024 | 85.97% |
| Mar 31, 2024 | 15.85% |
| Sep 30, 2023 | 89.43% |
| Jun 30, 2023 | 87.12% |
| Mar 31, 2023 | 90.35% |
| Dec 31, 2022 | 85.67% |
| Sep 30, 2022 | 72.62% |
| Jun 30, 2022 | 77.16% |
| Mar 31, 2022 | 93.03% |
| Dec 31, 2021 | 81.11% |
| Sep 30, 2021 | 97.91% |
| Jun 30, 2021 | 87.37% |
API Access
Kyntra Bio Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=KYNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "KYNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=KYNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();